Significant progress was made in the previous grant period in identifying signal transduction proteins in the brain that are altered by chronic antidepressant treatments. In the next grant period, we propose to considerably focus our attention on a subset of these adaptations, which will be characterized mechanistically in considerable depth. The major objective of this proposal is to explore the role of novel isoforms of the transcription factor"""""""" deltaFosB, in mediating the long-term actions of antidepressant treatments in brain. Previous work supported by this grant has established that chronic, but not acute, administration of several classes of antidepressants induces the deltaFosB isoforms in specific brain regions, particularly superficial layers of prefrontal cortex. DeltaFosB, due to its extraordinary stability, persists in brain for weeks after discontinuation of these treatments. Thus, induction of deltaFosB provides an attractive molecular mechanism for the delayed yet persistent changes in gene expression caused by chronic antidepressant exposure. The proposed studies win focus on specific glutamate receptor subunits as possible physiological targets for deltaFosB. We have found that antidepressant regulation of certain subunits, seen in superficial layers of prefrontal cortex of rats and wildtype mice, is abolished in fosB knockout mice. In addition, by use of inducible transgenic nuce recently developed in our laboratory, we have shown that overexpression of deltaFosB in prefrontal cortex mimics antidepressant regulation of these receptor subunits. Finally, the promoters of the genes for these regulated receptor subunits contain AP-1 sites (the DNA targets for AFosB) and are regulated upon overexpression of deltaFosB in cultured cells and neurons. Together, this work will establish deltaFosB as both a necessary and sufficient mediator of antidepressant regulation of glutamate receptor expression in the brain. Such regulation could contribute to the beneficial effects of these treatments in humans based on indirect evidence that has implicated glutamatergic transmission in antidepressant action. More fundamentally, however, the proposed studies will improve our general understanding of the precise molecular mechanisms that control the expression of glutamate receptors, key mediators of synaptic transmission, in the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH051399-09
Application #
6397786
Study Section
Special Emphasis Panel (ZRG1-MDCN-5 (01))
Program Officer
Brady, Linda S
Project Start
1994-09-30
Project End
2004-04-30
Budget Start
2001-09-01
Budget End
2002-04-30
Support Year
9
Fiscal Year
2001
Total Cost
$279,050
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Muir, Jessie; Lorsch, Zachary S; Ramakrishnan, Charu et al. (2018) In Vivo Fiber Photometry Reveals Signature of Future Stress Susceptibility in Nucleus Accumbens. Neuropsychopharmacology 43:255-263
Hamilton, Peter J; Burek, Dominika J; Lombroso, Sonia I et al. (2018) Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress. Neuropsychopharmacology 43:272-284
Lorsch, Zachary S; Loh, Yong-Hwee Eddie; Purushothaman, Immanuel et al. (2018) Estrogen receptor ? drives pro-resilient transcription in mouse models of depression. Nat Commun 9:1116
Hultman, Rainbo; Ulrich, Kyle; Sachs, Benjamin D et al. (2018) Brain-wide Electrical Spatiotemporal Dynamics Encode Depression Vulnerability. Cell 173:166-180.e14
Tan, Aaron; Costi, Sara; Morris, Laurel S et al. (2018) Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder. Mol Psychiatry :
Kaufman, Joan; Wymbs, Nicholas F; Montalvo-Ortiz, Janitza L et al. (2018) Methylation in OTX2 and related genes, maltreatment, and depression in children. Neuropsychopharmacology 43:2204-2211
Hamilton, Peter J; Lim, Carissa J; Nestler, Eric J et al. (2018) Viral Expression of Epigenome Editing Tools in Rodent Brain Using Stereotaxic Surgery Techniques. Methods Mol Biol 1767:205-214
Hamilton, Peter J; Lim, Carissa J; Nestler, Eric J et al. (2018) Neuroepigenetic Editing. Methods Mol Biol 1767:113-136
Akil, Huda; Gordon, Joshua; Hen, Rene et al. (2018) Treatment resistant depression: A multi-scale, systems biology approach. Neurosci Biobehav Rev 84:272-288
Mul, Joram D; Soto, Marion; Cahill, Michael E et al. (2018) Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ?FosB. Neuropsychopharmacology 43:1934-1942

Showing the most recent 10 out of 103 publications